Sign Up Today and Learn More About CoreTissue BioEngineering Stock
Invest in or calculate the value of your shares in CoreTissue BioEngineering or other pre-IPO companies through EquityZen's platform.
CoreTissue BioEngineering Stock (CORB)
CoreTissue BioEngineering develops artificial ligaments derived from biological tissues.
About CoreTissue BioEngineering Stock
Founded
2016
Industries
Software, Data and Analytics, Artificial Intelligence
CoreTissue BioEngineering Press Mentions
Stay in the know about the latest news on CoreTissue BioEngineering
Photo - Japanese Medtech Startup, CoreTissue BioEngineering, Becomes First Company Accepted Into Accelerator Program Backed by Mitsubishi Corporation (Americas) and Fogarty Innovation
businesswire • Aug 03, 2024
Logo - Japanese Medtech Startup, CoreTissue BioEngineering, Becomes First Company Accepted Into Accelerator Program Backed by Mitsubishi Corporation (Americas) and Fogarty Innovation
businesswire • Aug 03, 2024
Japanese Medtech Startup, CoreTissue BioEngineering, Becomes First Company Accepted Into Accelerator Program Backed by Mitsubishi Corporation (Americas) and Fogarty Innovation
businesswire • Aug 03, 2024
Container for storing biological tissue
patents • Apr 15, 2024
Medtech Startup CoreTissue BioEngineering to Be the First Japanese Startup at JPOD @ Boston
businesswire • Mar 16, 2022
CoreTissue BioEngineering Management
Leadership team at CoreTissue BioEngineering
CEO
Tadashi Takiguchi
Join now and verify your accreditation status to gain access to:
- CoreTissue BioEngineering current valuation
- CoreTissue BioEngineering stock price
- Available deals in CoreTissue BioEngineering and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in CoreTissue BioEngineering stock?
Accredited investors can buy pre-IPO stock in companies like CoreTissue BioEngineering through EquityZen funds. These investments are made available by existing CoreTissue BioEngineering shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell CoreTissue BioEngineering stock?
Shareholders can sell their CoreTissue BioEngineering stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
